Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for pyrazolo 1, 5- a] pyrimidines
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- A375, A549, H3122, PC-9, NCI-N87 and RT-112 cells treated with THZ1 and/or tyrosine kinase inhibitor
Most Relevant Literature
- An ecofriendly synthesis and DNA binding interaction study of some pyrazolo [1,5-a]pyrimidines deriv…
- Potent and selective pyrazolo[1,5-a]pyrimidine based inhibitors of B-Raf(V600E) kinase with favorabl…
- Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: a template-based approach--part 1.
- Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: a template-based approach--part 2.
- Synthesis and biological evaluation of novel F-18 labeled pyrazolo[1,5-a]pyrimidine derivatives: pot…
Most Relevant Clinical Trials
- The Effect of Antioxidants on Skin Blood Flow-BH4
- Parsaclisib With or Without Polatuzumab Vedotin Plus the Standard Drug Therapy in Patients With Newl…
- Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas
- Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patie…
- Lenalidomide, Umbralisib, and Ublituximab for the Treatment of Relapsed or Refractory Indolent Non-H…
